Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） Patient [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the safety and efficacy of hetrombopag olamine in patients with severe aplastic anemia has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Hetrombopag Olamine (Hetrombopag)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Severe Aplastic Anemia | Phase 1, Phase 2 | Status: COMPLETED